Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NXT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PGGT1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JUND - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF468 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FAM199X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMOD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF765 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM123 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YTHDF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL6IP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOB1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NMD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARD6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF21A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTSSA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJB9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on